Cspc Pharmaceutical | 1093 - Sales Revenues

Stock Price
9.02
Daily Change
-0.17 -1.85%
Monthly
-14.26%
Yearly
74.13%
Q1 Forecast
8.40

Cspc Pharmaceutical reported CNY6.62B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Jiangsu Hengrui CNY 7.43B 1.17B Sep/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Sh Fosun Pharma CNY 9.88B 125.79M Sep/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Wuxi Apptec CNY 11.53B 390M Sep/2025
Xeris Pharmaceuticals USD 85.81M 11.43M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025